Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

New chloptosins B and C from an Embleya strain exhibit synergistic activity against methicillin-resistant Staphylococcus aureus when combined with co-producing compound L-156,602

A Correction to this article was published on 17 May 2024

This article has been updated

Abstract

Two new dimeric cyclohexapeptides, chloptosins B and C, were discovered from the culture broth of Embleya sp. MM621-AF10 together with the known compounds chloptosin and L-156,602. The structures of the new chloptosins were determined by spectroscopic studies and advanced Marfey’s methods. The stereo structure of the constituent isoleucine was determined by C3 Marfey’s analysis. Chloptosins demonstrated potent antimicrobial activity against Gram-positive bacteria including drug-resistant strains of methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci with MICs of 0.5–2 µg ml−1. The antimicrobial activities of chloptosins were enhanced by addition of co-producing compound L-156,602, as shown by checkerboard analysis.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

Change history

References

  1. Umezawa K, Ikeda Y, Uchihata Y, Naganawa H, Kondo S. Chloptosin, an apoptosis-inducing dimeric cyclohexapeptide produced by Streptomyces. J Org Chem. 2000;65:459–63.

    Article  CAS  PubMed  Google Scholar 

  2. Hurley TR, Bunge RH, Willmer NE, Hokanson GC, French JC. PD 124,895 and PD 124,966, two new antitumor antibiotics. J Antibiot. 1986;39:1651–6.

    Article  CAS  Google Scholar 

  3. Hensen OD, et al. L-156,602, a C5a antagonist with a novel cyclic hexadepsipeptide structure from Streptomyces sp. MA6348. Fermentation, isolation and structure determination. J Antibiot. 1991;44:249–54.

    Article  Google Scholar 

  4. Komaki H, et al. Classification of ‘Streptomyces hyalinum’ Hamada and Yokoyama as Embleya hyalina sp. nov., the second species in the genus Embleya, and emendation of the genus Embleya. Int J Syst Evol Microbiol. 2020;70:1591–5.

    Article  CAS  PubMed  Google Scholar 

  5. Nouioui I, et al. Genome-based taxonomic classification of the phylum actinobacteria. Front Microbiol. 2018;22:2007.

    Article  Google Scholar 

  6. Harada K, et al. Application of D, L-FDLA derivatization to determination of absolute configulation of constituent amino acids in peptide by advanced Marfey’s method. Tetrahedron Lett. 1996;37:3001–4.

    Article  CAS  Google Scholar 

  7. Kikuchi H, et al. Isolation of a cyclic depsipeptide, aspergillicin F and synthesis of aspergillicins with innate immune-modulating activity. J Nat Prod. 2015;78:1949–56.

    Article  CAS  PubMed  Google Scholar 

  8. Vijayasarathy S, et al. C3 and 2D C3 Marfey’s methods for amino acid analysis in natural products. J Nat Prod. 2016;79:421–7.

    Article  CAS  PubMed  Google Scholar 

  9. Moody, J. Synergism testing: broth microdilution checkerboard and broth macrodilution methods. in Clinical Microbiology Procedures Handbook 2nd edn (eds Garcia LS & Isenberg HD) (ASM Press, Washington, DC, 5.12.1–5.12.23, 2007).

  10. Komatsu M, Uchiyama T, Omura S, Cane DE, Ikeda H. Genome-minimized Streptomyces host for the heterologous expression of secondary metabolism. Proc Natl Acad Sci USA. 2010;107:2646–51.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Komatsu M, et al. Engineered Streptomyces avermitilis host for heterologous expression of biosynthetic gene cluster for secondary metabolites. ACS Synth Biol. 2013;19:384–96.

    Article  Google Scholar 

Download references

Acknowledgements

The authors are grateful to Ms Yuko Takahashi at the Institute of Microbial Chemistry (BIKAKEN), Tokyo, for the LC-MS measurements. We thank Renee Mosi, PhD, from Edanz Group (https://en-author-services.edanzgroup.com/) for editing a draft of this manuscript.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hideki Hashizume.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

The original online version of this article was revised: It has come to the attention of the authors that there was an error in Figure 1 of the original article. Specifically, the depiction of the carboxylic acid group of threonine in the right half of the structures of chloptosins was missing. The correct figure is below. The original article has been corrected.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hashizume, H., Harada, S., Sawa, R. et al. New chloptosins B and C from an Embleya strain exhibit synergistic activity against methicillin-resistant Staphylococcus aureus when combined with co-producing compound L-156,602. J Antibiot 74, 80–85 (2021). https://doi.org/10.1038/s41429-020-0361-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41429-020-0361-y

This article is cited by

Search

Quick links